Medtronic acquires Heartware, a manufacturer of left ventricular assist devices (LVAD) for $1.1 billion

Recently, Medtronic and the left ventricular assist device (LVAD) manufacturer Heartware reached a final agreement, the former will acquire the latter for a transaction with a total price of about $11. Under the agreement, Medtronic will pay $58 per share in cash for all issued shares of HeartWare common stock. The board of directors of both companies has approved the transaction. The acquisition is expected to be completed by the end of October this year.

HeartWare's main product is the HVAD system, a very small ventricular assist device (VAD) that is a very small ventricular assist device (VAD) that reduces surgical trauma, reduces patient recovery time, and improves clinical outcomes. In addition, HeartWare has a number of technologies under development to provide a more minimally invasive mechanical cycle assist option for patients with end-stage heart failure. Medtronic expects: VAD's global market size is currently about 800 million US dollars. It is expected to achieve a single-digit growth in the middle and high positions in 2016, and will achieve high single digit/low double digit growth in the next few years.

Medtronic’s acquisition will provide an opportunity for anti-heart failure in the field of anti-heart failure, with a focus on achieving smaller and faster increases in the late-stage sales (single-digit high value) in response to previous pacemakers and implantable rhythm Sales of mature devices such as defibrillators (ICDs) have stabilized.

Needle Holder

Needle Holder,Needle Holder Gun Type Handle,Laparoscopic Hernia Needle,Hernia Forceps

ZHEJIANG SHENDASIAO MEDICAL INSTRUMENT CO.,LTD. , https://www.shendasiaomed.com